CHICAGO, IL—Am Law 100 firm Polsinelli welcomes Michelle McMullen, Ph.D. to its Intellectual Property Department in Chicago and Raleigh, N.C.
Dr. McMullen joins the firm as a shareholder with over 20 years of experience in intellectual property law and a deep understanding of biotechnology, pharmaceutical and medical technologies that provides clients with real world perspective and guidance. Her strategic patent counseling includes developing comprehensive IP strategies for licensing, patent-related disputes, patentability requirements and freedom to operate concerns.
Within her varied practice, Dr. McMullen represents a wide range of biotechnology companies, university clients and start-ups, and works closely with licensing, regulatory, litigation and foreign counsel to coordinate international patent prosecution. Specifically, Dr. McMullen’s IP diligence practice includes assessment of the strength and weakness of client and third-party patent portfolios and recommendations for maximizing value of patent portfolios.
Additionally, Dr. McMullen brings a robust scientific research background to Polsinelli. She holds a Ph.D. in Biochemistry, Molecular and Cellular Biology from Northwestern University, and her academic and research backgrounds inform her IP practice, which encompasses emerging developments in diagnostics, pharmaceuticals and vaccines, as well as metabolomics and stem-cell technologies.
Dr. McMullen is a graduate of the DePaul University College of Law. Prior to completing her Ph.D. at Northwestern, she earned a B.S. in Microbiology, with distinction, from the University of Illinois at Urbana-Champaign.